116 related articles for article (PubMed ID: 9710399)
1. Differential effect of halothane and forskolin on platelet cytosolic Ca2+ mobilization and aggregation.
Corbin F; Blaise G; Sauvé R
Anesthesiology; 1998 Aug; 89(2):401-10. PubMed ID: 9710399
[TBL] [Abstract][Full Text] [Related]
2. Direct inhibitory mechanisms of halothane on human platelet aggregation.
Kohro S; Yamakage M
Anesthesiology; 1996 Jul; 85(1):96-106; discussion 30A. PubMed ID: 8694388
[TBL] [Abstract][Full Text] [Related]
3. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
Ohkubo S; Nakahata N; Ohizumi Y
Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
[TBL] [Abstract][Full Text] [Related]
4. Sevoflurane does not inhibit human platelet aggregation induced by thrombin.
Nozuchi S; Mizobe T; Aoki H; Hiramatsu N; Kageyama K; Amaya F; Uemura K; Fujimiya T
Anesthesiology; 2000 Jan; 92(1):164-70. PubMed ID: 10638913
[TBL] [Abstract][Full Text] [Related]
5. Effects of prostaglandins, cAMP, and changes in cytosolic calcium on platelet aggregation induced by a thromboxane A2 mimic (U46619).
Yun JC; Ohman KP; Gill JR; Keiser H
Can J Physiol Pharmacol; 1991 May; 69(5):599-604. PubMed ID: 1650650
[TBL] [Abstract][Full Text] [Related]
6. Different effects of endothelin-3 on the Ca2+ discharge induced by agonists and Ca(2+)-ATPase inhibitors in human platelets.
Astarie-Dequeker C; Korichneva I; Devynck MA
Br J Pharmacol; 1995 Jan; 114(2):524-30. PubMed ID: 7881751
[TBL] [Abstract][Full Text] [Related]
7. Inhibition by forskolin of cytosolic calcium rise, shape change and aggregation in quin2-loaded human platelets.
Sage SO; Rink TJ
FEBS Lett; 1985 Aug; 188(1):135-40. PubMed ID: 2410292
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of GBH on platelet aggregation through inhibition of intracellular Ca2+ mobilization in activated human platelets.
Park WH; Kim HK; Nam KS; Shon YH; Jeon BH; Moon SK; Kim MG; Kim CH
Life Sci; 2004 Nov; 75(25):3063-76. PubMed ID: 15474558
[TBL] [Abstract][Full Text] [Related]
9. Effects of halothane and isoflurane on bradykinin-evoked Ca2+ influx inbovine aortic endothelial cells.
Simoneau C; Thuringer D; Cai S; Garneau L; Blaise G; Sauvé R
Anesthesiology; 1996 Aug; 85(2):366-79. PubMed ID: 8712453
[TBL] [Abstract][Full Text] [Related]
10. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E
Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526
[TBL] [Abstract][Full Text] [Related]
11. Ni2+ impairs thrombin-induced signal transduction by acting on the agonist and/or receptor in human platelets.
Azula FJ; Alonso R; Marino A; Trueba M; Macarulla JM
Am J Physiol; 1993 Dec; 265(6 Pt 1):C1681-8. PubMed ID: 8279529
[TBL] [Abstract][Full Text] [Related]
12. Role of cyclic AMP in adenosine inhibition of intracellular calcium rise in human platelets. Comparison of adenosine effects on thrombin- and epinephrine-induced platelet stimulation.
Feoktistov IA; Paul S; Hollister AS; Robertson D; Biaggioni I
Am J Hypertens; 1992 Jun; 5(6 Pt 2):147S-153S. PubMed ID: 1321639
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of phenol derivatives on bovine platelet aggregation and their effects on Ca2+ mobilization.
Kitagawa S; Ito Y; Oda Y; Kametani F
Biochim Biophys Acta; 1989 Mar; 1011(1):52-7. PubMed ID: 2493810
[TBL] [Abstract][Full Text] [Related]
14. Effects of forskolin and organic nitrate on aggregation and intracellular cyclic nucleotide content in human platelets.
Anfossi G; Massucco P; Mularoni E; Cavalot F; Mattiello L; Trovati M
Gen Pharmacol; 1994 Oct; 25(6):1093-100. PubMed ID: 7875530
[TBL] [Abstract][Full Text] [Related]
15. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
Aoki T; Tomiyama Y; Honda S; Senzaki K; Tanaka A; Okubo M; Takahashi F; Takasugi H; Seki J
Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446
[TBL] [Abstract][Full Text] [Related]
16. Synergistic responses in human platelets. Comparison between aggregation, secretion and cytosolic Ca2+ concentration.
Thompson NT; Scrutton MC; Wallis RB
Eur J Biochem; 1986 Dec; 161(2):399-408. PubMed ID: 3490977
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of platelet aggregation by unsaturated fatty acids through interference with a thromboxane-mediated process.
Sato T; Nakao K; Hashizume T; Fujii T
Biochim Biophys Acta; 1987 Nov; 931(2):157-64. PubMed ID: 3663714
[TBL] [Abstract][Full Text] [Related]
18. Toborinone and olprinone, phosphodiesterase III inhibitors, inhibit human platelet aggregation due to the inhibition of both calcium release from intracellular stores and calcium entry.
Kageyama K; Mizobe T; Nozuchi S; Hiramatsu N; Nakajima Y; Aoki H
J Anesth; 2004; 18(2):107-12. PubMed ID: 15127258
[TBL] [Abstract][Full Text] [Related]
19. Calcium-induced platelet aggregation in washed platelets from guinea pigs.
Miyamae T; Oshima K; Morikawa T; Hagiwara M
Pharmacology; 1995 Sep; 51(3):180-5. PubMed ID: 7501704
[TBL] [Abstract][Full Text] [Related]
20. Effects of halothane and isoflurane on beta-adrenoceptor-mediated responses in the vascular smooth muscle of rat aorta.
Tanaka S; Tsuchida H
Anesthesiology; 1998 Nov; 89(5):1209-17. PubMed ID: 9822010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]